Developer docs
API playgroundTry for free, no card

Search company profiles

Hillhouse Capital

Full company profile

uuid0000yf1

Namestring
Hillhouse Capital
Legal namestring
Hillhouse Investment (高瓴投资)
Company typeenum
Private
Founded yearint
2005
Descriptiontext

Hillhouse Capital is a private investment management firm founded in 2005 by Zhang Lei with seed capital from the Yale Endowment, operating under an evergreen fund (长青基金) structure that allows multi-decade capital deployment without exit pressure. The firm invests globally across five primary verticals — healthcare and life sciences, consumer and retail, technology and internet, manufacturing and energy transition, and enterprise services — using a research-driven methodology that traces its lineage to David Swensen's Yale endowment model. Notable portfolio realizations include long-term holdings through the April 2019 NASDAQ IPO of Zoom Video Communications (US$9.2 billion valuation) and the October 2019 Hong Kong Stock Exchange listing of Topsports International (HK$7.62 billion raised, market cap exceeding HK$53 billion at debut).

The firm's product stack centers on the flagship Hillhouse Investment platform and extends across the GL Ventures (高瓴创投) early-stage venture capital arm, the annual HCare Global Health Industry Summit (8th edition held June 2024), the Gaoli Value Investment Research Institute and Gaoli Research Institute (高礼研究院) for value-investing education and talent cultivation, and operating joint ventures such as Huimei Medical Management with Mayo Clinic (launched January 2015 at Diaoyutai State Guesthouse). Recent 2025–2026 activity includes lead or co-lead positions in Dify (US$30M at US$180M valuation), ZAST.AI (US$6M Pre-A), Xinghai Map (RMB 1B Series B at RMB 10B valuation), AGILINK (two strategic rounds), Yushi Space (RMB 200M Pre-A+), and reported participation in DeepSeek's first external round at up to US$50 billion valuation.

Hillhouse generates revenue through standard PE/VC economics — management fees and carried interest — sourced from a concentrated base of ultra-long-term institutional LPs including the Yale Endowment, family offices, sovereign wealth funds, and pension funds. The evergreen fund structure eliminates forced distributions and enables compounding AUM growth, with disclosed AUM having grown from US$11 billion in 2014 to over US$23 billion by 2015. Distribution is relationship-driven, anchored on direct founder outreach, the annual Ling Summit (顶峰会), the HCare summit, syndicate co-investments with top-tier VC/PE firms (HSG, Tencent, Meituan, IDG Capital, ByteDance, Matrix Partners, GGV Capital, GSR Ventures), and ecosystem partnerships spanning Zhongguancun, Yale University, Renmin University, Westlake University, Future Forum, and Bainian Vocational School.

Short descriptiontext

Hillhouse Capital is a private investment management firm founded in 2005 by Zhang Lei, operating as an evergreen fund that invests globally across healthcare, consumer, technology, manufacturing, and energy transition, serving institutional LPs including university endowments and sovereign wealth funds.

Operating statusenum
Operating
Ownership categoryenum
akta.pro rankint
HeadquartersZhuhai, China
HQ citystring
Zhuhai
HQ countrystring
China
HQ regionstring
Asia
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
private equity, venture capital, investment management, evergreen fund, long-term capital
Industry2 codes
1Warehouse / Facility Providers to Venture Lenders
CodeFSANAIALPrimaryYes
2Emerging Manager / Seeding Platforms (Multi-Manager)
CodeFSANAGAFPrimaryNo
NAICS code2 codes
  • Portfolio Management and Investment Advice523940
  • Funds, Trusts, and Other Financial Vehicles525
SIC code1 code
  • Investment Advice6282
Product category
Private Equity / Investment Management
No data
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model2 records
1Long-term capital investment returns
TypeManaged Services
Description

As an evergreen fund (长青基金) structure, Hillhouse generates revenue through long-horizon investments across healthcare, manufacturing, energy transition, enterprise services, and consumer sectors. The fund does not face exit pressure and can hold positions across early, growth, late, pre-IPO, and post-IPO stages, allowing patient compounding of returns over decades.

hillhouseinvestment.cn
2Limited partner management fees and carried interest
TypeSubscription Recurring
Description

Hillhouse manages capital from ultra-long-term LPs including university endowments (Yale), family offices, sovereign wealth funds, and pension funds. Standard PE/VC fee structure applies, with the firm explicitly targeting alignment of interest ('利益一致原则') with investors.

hillhouseinvestment.cn
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Pricing details1 tier
1Quote-based / Not publicly disclosed
ModelOtherBilling cadenceMulti-year contract
Notes

Hillhouse operates an evergreen fund model (长青基金) with LPs including university endowments, family funds, pension funds, and sovereign wealth funds. Fund terms are negotiated privately with no public disclosure of management fees or carried interest rates.

hillhouseinvestment.cn
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 2 records shown
1GL Ventures (高瓴创投)
Description

Hillhouse's early-stage venture capital arm, operated as a distinct branded unit with its own WeChat official account.

hillhouseinvestment.cn
+1 more record
Core offering1 text field

Hillhouse Capital operates a research-driven, long-term value investment management platform structured as an evergreen fund (长青基金). The firm invests globally across healthcare, manufacturing, energy transition, enterprise services, and consumer sectors through direct equity, venture, growth, pre-IPO, and post-IPO stages, partnering with high-quality management teams and providing both capital and operational support ("Solution Capital") to portfolio companies. Hillhouse maintains a venture capital subsidiary (GL Ventures/高瓴创投) for early-stage investments and curates industry events (HCare Global Health Industry Summit, Lings Summit) to convene founders and institutional investors.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Topsports IPO raised HK$7.62 billion at HK$8.5/share, achieving market cap exceeding HK$53 billion
+3 more records
Product overview1 text field

Hillhouse Capital operates as a long-term value investment management firm built on an Evergreen Fund (长青基金) structure, rather than as a single unified software product or modular platform. Its core offering — Hillhouse Investment (高瓴投资) — delivers research-driven, sector-focused investments globally across healthcare, manufacturing, energy transition, enterprise services, and consumer sectors, partnering with ultra-long-term LPs including university endowments, family funds, pension funds, and sovereign wealth funds. Around this core the firm maintains the GL Ventures (高瓴创投) venture capital subsidiary for early-stage technology bets, the HCare Global Health Industry Summit (HCare全球健康产业峰会) annual healthcare industry event series, the Gaoli Value Investment Research Institute (高礼价值投资研究院) and Gaoli Research Institute (高礼研究院) for value-investing education and talent cultivation, and operating joint ventures such as Huimei Medical Management (惠每医疗) with Mayo Clinic. Hillhouse's long-term portfolio holdings — including Zoom (ZM, listed April 2019) and Topsports International (滔搏国际, 06110.HK, listed October 2019) — reflect the firm's long-horizon partnership model with portfolio companies.

Product and service6 records
1Hillhouse Investment (高瓴投资) — Evergreen Fund
CategoryPrivate Equity / Investment Management
2GL Ventures (高瓴创投)
CategoryVenture Capital / Early-stage Investment
3HCare Global Health Industry Summit (HCare全球健康产业峰会)
CategoryIndustry Event / Summit Series
4Gaoli Value Investment Research Institute (高礼价值投资研究院)
CategoryEducational / Research Institute
5Huimei Medical Management Co., Ltd. (惠每医疗管理有限公司)
CategoryJoint Venture / Operating Business
6Gaoli Research Institute (高礼研究院)
CategoryEducational / Talent Development Platform
Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-29
Description

Hillhouse Capital signed (March 29, 2026) as an ecosystem partner for the International Innovation Service Aggrarian Area at Haidian District, Beijing, alongside Sequoia China, Matrix Partners, GGV Capital, GSR Ventures, and Zhenzhi Capital. The partnership aims to accelerate technology transfer from university laboratories to market commercialization.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2018-03-01
Description

Hillhouse founder Zhang Lei (张磊) served as founding donor and current 创校校董 (founding board member) and Development Committee Chair for Westlake University, a new privately-funded international research university established by prominent Chinese scientists including Shi Yigong and Rao Yi. The university received formal Ministry of Education approval on April 2, 2018.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2018-03-01
Description

Hillhouse founder Zhang Lei is a founding council member (创始理事) of the Future Forum, a public welfare organization launched in 2015 by leaders in internet, investment, science, and education. He serves as donor of the 'Future Science Award' prize fund and was elected 2019 Council Rotating Chairman at the end of 2018.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2015-01-01
Description

Hillhouse established a joint venture with Mayo Clinic called 惠每医疗管理有限公司 (Huimei Medical Management Co., Ltd.), officially launched on January 21, 2015 at Diaoyutai State Guesthouse in Beijing. The partnership imports Mayo Clinic's medical technology, management systems, training curricula, clinical decision support, and patient education content (covering 10,000+ diseases) into the Chinese healthcare market.

5Bainian Vocational Education Workshop (百年职教工作坊)
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2011-05-01
Description

Hillhouse supports the Bainian Vocational Education Workshop, an industry exchange activity initiated by Bainian Vocational School in 2014 to promote innovation in vocational education teaching reform and advanced practical models.

hillhouseinvestment.cn
6Bainian Vocational School (百年职校) / Zhengzhou Bainian Gaoli Vocational School
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2011-03-01
Description

Hillhouse has long-term supported Bainian Vocational School, China's first fully-free public welfare vocational school founded in 2005. Hillhouse funded the establishment of the Zhengzhou Bainian Gaoli Vocational School. The school serves children of migrant workers, young migrant workers, and impoverished families with three-year programs fully covered by sponsorship.

hillhouseinvestment.cn
7Gaoli Institute (高礼研究院) at Renmin University of China
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2011-01-01
Description

Hillhouse founder Zhang Lei donated to establish the Gaoli Institute at Renmin University of China in 2011, with support from then-People's University President Chen Yulu and then-Yale President Richard Levin. The institute provides a world-class platform for cultivating future youth leaders, with programs including the Gaoli Elite Cultivation Plan, Yale Summer School, SHero Women's Leadership program, and more. Over 500+ Gaoli talents have graduated and are placed at Yale, Harvard, Stanford, Oxford, and leading global institutions.

hillhouseinvestment.cn
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2010-03-01
Description

Hillhouse donated US$8.8888 million to Yale University School of Management in March 2010 for new campus construction, scholarship establishment, and Yale-China teaching activities. Founder Zhang Lei serves as a Yale Corporation member (耶鲁大学校务委员会委员) and chair of Yale's Asia Development Committee.

9Zhumadian Senior High School (河南驻马店高级高中)
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2010-03-01
Description

Hillhouse established the 'Hillhouse 107 Scholarship' (高瓴·107奖学金) at Zhumadian Senior High School in 2010, named after the founder's former class. It is the first alumni-funded scholarship at the school, supporting outstanding and financially-needy students. The scholarship has operated for 10+ years.

hillhouseinvestment.cn
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Carlyle is a global incumbent alternatives manager with a sizable Asia platform; Hillhouse has appeared alongside Carlyle in the reported Starbucks China stake sale process, illustrating overlapping access to the largest Asian consumer/retail transactions.

TypeDirect peer
Description

IDG Capital is one of China's earliest and largest VC/PE platforms, frequently co-investing with Hillhouse across technology, consumer, and healthcare rounds and competing for the same early-to-growth stage Chinese founders.

TypeDirect peer
Description

Boyu is a top-tier Asia-focused private equity firm (founded 2011 by Tong Zixi ex-TPG) executing large-cap growth, buyout, and healthcare investments across Greater China, directly competing with Hillhouse for control and growth deals in the same sectors.

TypeDirect peer
Description

Matrix Partners China is an early- and growth-stage China venture firm that regularly co-invests and competes with Hillhouse/GL Ventures in seed-to-Series B rounds in TMT, consumer, and healthcare.

TypeDirect peer
Description

CDH was one of the largest China-focused PE platforms with a comparable evergreen-like approach, broad sector mandate (consumer, healthcare, industrials), and similar GP-led scaling trajectory; now operating under Bain Capital.

TypeDirect peer
Description

Hopu is a large, long-horizon China/Asia investment platform founded by Fang Fenglei, with a similar long-term capital base, large-check consumer and financial services bets, and operational focus paralleling Hillhouse's model.

TypeDirect peer
Description

Citic Capital is a Hong Kong-headquartered alternatives manager that invests in control and growth equity across China, consumer, healthcare, and industrials — directly comparable to Hillhouse on mandate, ticket size, and Chinese LP / state-affiliated access.

TypeEmerging player
Description

Tencent's corporate venture and growth arm is a recurring co-investor and competitor with Hillhouse in Chinese AI, consumer tech, and gaming — co-participating in rounds such as DeepSeek's reported US$50B financing.

TypeDirect peer
Description

HSG is Hillhouse's most direct and frequent co-investor in Chinese growth and venture rounds, operating a similar multi-stage, multi-vertical China/Asia investment platform with comparable LPs and exit pathways (IPO on HKEX, NASDAQ, STAR).

TypeBroad incumbent
Description

KKR's Asia Pacific platform pursues large-cap control and growth deals in consumer, healthcare, and tech across the region, providing a global incumbent benchmark against which Hillhouse's Asia-centric, founder-driven model is measured.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment7 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment110 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Hillhouse Capital

Private Equity / Investment Managementhillhouseinvestment.cn

Hillhouse Capital is a private investment management firm founded in 2005 by Zhang Lei, operating as an evergreen fund that invests globally across healthcare, consumer, technology, manufacturing, and energy transition, serving institutional LPs including university endowments and sovereign wealth funds.

What Hillhouse Capital does

Hillhouse Capital is a private investment management firm founded in 2005 by Zhang Lei with seed capital from the Yale Endowment, operating under an evergreen fund (长青基金) structure that allows multi-decade capital deployment without exit pressure. The firm invests globally across five primary verticals — healthcare and life sciences, consumer and retail, technology and internet, manufacturing and energy transition, and enterprise services — using a research-driven methodology that traces its lineage to David Swensen's Yale endowment model. Notable portfolio realizations include long-term holdings through the April 2019 NASDAQ IPO of Zoom Video Communications (US$9.2 billion valuation) and the October 2019 Hong Kong Stock Exchange listing of Topsports International (HK$7.62 billion raised, market cap exceeding HK$53 billion at debut).

The firm's product stack centers on the flagship Hillhouse Investment platform and extends across the GL Ventures (高瓴创投) early-stage venture capital arm, the annual HCare Global Health Industry Summit (8th edition held June 2024), the Gaoli Value Investment Research Institute and Gaoli Research Institute (高礼研究院) for value-investing education and talent cultivation, and operating joint ventures such as Huimei Medical Management with Mayo Clinic (launched January 2015 at Diaoyutai State Guesthouse). Recent 2025–2026 activity includes lead or co-lead positions in Dify (US$30M at US$180M valuation), ZAST.AI (US$6M Pre-A), Xinghai Map (RMB 1B Series B at RMB 10B valuation), AGILINK (two strategic rounds), Yushi Space (RMB 200M Pre-A+), and reported participation in DeepSeek's first external round at up to US$50 billion valuation.

Hillhouse generates revenue through standard PE/VC economics — management fees and carried interest — sourced from a concentrated base of ultra-long-term institutional LPs including the Yale Endowment, family offices, sovereign wealth funds, and pension funds. The evergreen fund structure eliminates forced distributions and enables compounding AUM growth, with disclosed AUM having grown from US$11 billion in 2014 to over US$23 billion by 2015. Distribution is relationship-driven, anchored on direct founder outreach, the annual Ling Summit (顶峰会), the HCare summit, syndicate co-investments with top-tier VC/PE firms (HSG, Tencent, Meituan, IDG Capital, ByteDance, Matrix Partners, GGV Capital, GSR Ventures), and ecosystem partnerships spanning Zhongguancun, Yale University, Renmin University, Westlake University, Future Forum, and Bainian Vocational School.

Hillhouse Capital firmographics

Firmographics
Name
Hillhouse Capital
Legal name
Hillhouse Investment (高瓴投资)
Website
https://hillhouseinvestment.cn
Company type
Private
Founded year
2005
Operating status
Operating
Short description
Hillhouse Capital is a private investment management firm founded in 2005 by Zhang Lei, operating as an evergreen fund that invests globally across healthcare, consumer, technology, manufacturing, and energy transition, serving institutional LPs including university endowments and sovereign wealth funds.
Ownership category
akta.pro rank

Hillhouse Capital industry classification

Industry
Product category
Private Equity / Investment Management
NAICS
Portfolio Management and Investment Advice (523940), Funds, Trusts, and Other Financial Vehicles (525)
SIC
Investment Advice (6282)
akta.pro primary industry
Warehouse / Facility Providers to Venture Lenders (FSANAIAL)
akta.pro secondary industry
Emerging Manager / Seeding Platforms (Multi-Manager) (FSANAGAF)

Keywords

  • Private equity
  • Venture capital
  • Investment management
  • Evergreen fund
  • Long-term capital

Where Hillhouse Capital is headquartered

Location

Headquarters

HQ city
Zhuhai
HQ country
China
HQ region
Asia

Offices2 records

Markets served

Hillhouse Capital business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

  1. Long-term capital investment returns: As an evergreen fund (长青基金) structure, Hillhouse generates revenue through long-horizon investments across healthcare, manufacturing, energy transition, enterprise services, and consumer sectors. The fund does not face exit pressure and can hold positions across early, growth, late, pre-IPO, and post-IPO stages, allowing patient compounding of returns over decades.
  2. Limited partner management fees and carried interest: Hillhouse manages capital from ultra-long-term LPs including university endowments (Yale), family offices, sovereign wealth funds, and pension funds. Standard PE/VC fee structure applies, with the firm explicitly targeting alignment of interest ('利益一致原则') with investors.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractQuote-based / Not publicly disclosed

Go-to-market motion3 records

Distribution channels4 records

Marketing channels7 records

Hillhouse Capital product offering

Product offering

Core offering

Hillhouse Capital operates a research-driven, long-term value investment management platform structured as an evergreen fund (长青基金). The firm invests globally across healthcare, manufacturing, energy transition, enterprise services, and consumer sectors through direct equity, venture, growth, pre-IPO, and post-IPO stages, partnering with high-quality management teams and providing both capital and operational support ("Solution Capital") to portfolio companies. Hillhouse maintains a venture capital subsidiary (GL Ventures/高瓴创投) for early-stage investments and curates industry events (HCare Global Health Industry Summit, Lings Summit) to convene founders and institutional investors.

Product overview

Hillhouse Capital operates as a long-term value investment management firm built on an Evergreen Fund (长青基金) structure, rather than as a single unified software product or modular platform. Its core offering — Hillhouse Investment (高瓴投资) — delivers research-driven, sector-focused investments globally across healthcare, manufacturing, energy transition, enterprise services, and consumer sectors, partnering with ultra-long-term LPs including university endowments, family funds, pension funds, and sovereign wealth funds. Around this core the firm maintains the GL Ventures (高瓴创投) venture capital subsidiary for early-stage technology bets, the HCare Global Health Industry Summit (HCare全球健康产业峰会) annual healthcare industry event series, the Gaoli Value Investment Research Institute (高礼价值投资研究院) and Gaoli Research Institute (高礼研究院) for value-investing education and talent cultivation, and operating joint ventures such as Huimei Medical Management (惠每医疗) with Mayo Clinic. Hillhouse's long-term portfolio holdings — including Zoom (ZM, listed April 2019) and Topsports International (滔搏国际, 06110.HK, listed October 2019) — reflect the firm's long-horizon partnership model with portfolio companies.

Differentiator

Problem solved

Functional benefit

Brands

  • GL Ventures (高瓴创投): Hillhouse's early-stage venture capital arm, operated as a distinct branded unit with its own WeChat official account.
  • Hillhouse Time (高瓴时间)

Products and services

  • Hillhouse Investment (高瓴投资) — Evergreen Fund
  • GL Ventures (高瓴创投)
  • HCare Global Health Industry Summit (HCare全球健康产业峰会)
  • Gaoli Value Investment Research Institute (高礼价值投资研究院)
  • Huimei Medical Management Co., Ltd. (惠每医疗管理有限公司)
  • Gaoli Research Institute (高礼研究院)

Quantifiable outcome

  • Topsports IPO raised HK$7.62 billion at HK$8.5/share, achieving market cap exceeding HK$53 billion
  • +3 more outcomes

Companies that use Hillhouse Capital

Customer profile

Named customers10 records

Segments7 records

Ideal customer profiles2 records

Hillhouse Capital technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Hillhouse Capital partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered core, flagship and minor.

  • Zhongguancun International Innovation Service Aggrarian Area (Ecosystem Partner consortium)coreStrategic or Co-development Partner · 29 March 2026Hillhouse Capital signed (March 29, 2026) as an ecosystem partner for the International Innovation Service Aggrarian Area at Haidian District, Beijing, alongside Sequoia China, Matrix Partners, GGV Capital, GSR Ventures, and Zhenzhi Capital. The partnership aims to accelerate technology transfer from university laboratories to market commercialization.
  • Westlake University (西湖大学)flagshipStrategic or Co-development Partner · 1 March 2018Hillhouse founder Zhang Lei (张磊) served as founding donor and current 创校校董 (founding board member) and Development Committee Chair for Westlake University, a new privately-funded international research university established by prominent Chinese scientists including Shi Yigong and Rao Yi. The university received formal Ministry of Education approval on April 2, 2018.
  • Future Forum (未来论坛)flagshipStrategic or Co-development Partner · 1 March 2018Hillhouse founder Zhang Lei is a founding council member (创始理事) of the Future Forum, a public welfare organization launched in 2015 by leaders in internet, investment, science, and education. He serves as donor of the 'Future Science Award' prize fund and was elected 2019 Council Rotating Chairman at the end of 2018.
  • Mayo ClinicflagshipStrategic or Co-development Partner · 1 January 2015Hillhouse established a joint venture with Mayo Clinic called 惠每医疗管理有限公司 (Huimei Medical Management Co., Ltd.), officially launched on January 21, 2015 at Diaoyutai State Guesthouse in Beijing. The partnership imports Mayo Clinic's medical technology, management systems, training curricula, clinical decision support, and patient education content (covering 10,000+ diseases) into the Chinese healthcare market.
  • Bainian Vocational Education Workshop (百年职教工作坊)minorStrategic or Co-development Partner · 1 May 2011Hillhouse supports the Bainian Vocational Education Workshop, an industry exchange activity initiated by Bainian Vocational School in 2014 to promote innovation in vocational education teaching reform and advanced practical models.
  • Bainian Vocational School (百年职校) / Zhengzhou Bainian Gaoli Vocational SchoolcoreStrategic or Co-development Partner · 1 March 2011Hillhouse has long-term supported Bainian Vocational School, China's first fully-free public welfare vocational school founded in 2005. Hillhouse funded the establishment of the Zhengzhou Bainian Gaoli Vocational School. The school serves children of migrant workers, young migrant workers, and impoverished families with three-year programs fully covered by sponsorship.
  • Gaoli Institute (高礼研究院) at Renmin University of ChinaflagshipStrategic or Co-development Partner · 1 January 2011Hillhouse founder Zhang Lei donated to establish the Gaoli Institute at Renmin University of China in 2011, with support from then-People's University President Chen Yulu and then-Yale President Richard Levin. The institute provides a world-class platform for cultivating future youth leaders, with programs including the Gaoli Elite Cultivation Plan, Yale Summer School, SHero Women's Leadership program, and more. Over 500+ Gaoli talents have graduated and are placed at Yale, Harvard, Stanford, Oxford, and leading global institutions.
  • Yale University (耶鲁大学)flagshipStrategic or Co-development Partner · 1 March 2010Hillhouse donated US$8.8888 million to Yale University School of Management in March 2010 for new campus construction, scholarship establishment, and Yale-China teaching activities. Founder Zhang Lei serves as a Yale Corporation member (耶鲁大学校务委员会委员) and chair of Yale's Asia Development Committee.
  • Zhumadian Senior High School (河南驻马店高级高中)minorStrategic or Co-development Partner · 1 March 2010Hillhouse established the 'Hillhouse 107 Scholarship' (高瓴·107奖学金) at Zhumadian Senior High School in 2010, named after the founder's former class. It is the first alumni-funded scholarship at the school, supporting outstanding and financially-needy students. The scholarship has operated for 10+ years.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Hillhouse Capital competitors and assessment

Company assessment

Broad incumbents

  • Carlyle Group: Carlyle is a global incumbent alternatives manager with a sizable Asia platform; Hillhouse has appeared alongside Carlyle in the reported Starbucks China stake sale process, illustrating overlapping access to the largest Asian consumer/retail transactions.
  • KKR Asia: KKR's Asia Pacific platform pursues large-cap control and growth deals in consumer, healthcare, and tech across the region, providing a global incumbent benchmark against which Hillhouse's Asia-centric, founder-driven model is measured.

Direct peers

  • IDG Capital: IDG Capital is one of China's earliest and largest VC/PE platforms, frequently co-investing with Hillhouse across technology, consumer, and healthcare rounds and competing for the same early-to-growth stage Chinese founders.
  • Boyu Capital: Boyu is a top-tier Asia-focused private equity firm (founded 2011 by Tong Zixi ex-TPG) executing large-cap growth, buyout, and healthcare investments across Greater China, directly competing with Hillhouse for control and growth deals in the same sectors.
  • Matrix Partners China: Matrix Partners China is an early- and growth-stage China venture firm that regularly co-invests and competes with Hillhouse/GL Ventures in seed-to-Series B rounds in TMT, consumer, and healthcare.
  • CDH Investments (now Bain Capital Asia): CDH was one of the largest China-focused PE platforms with a comparable evergreen-like approach, broad sector mandate (consumer, healthcare, industrials), and similar GP-led scaling trajectory; now operating under Bain Capital.
  • Hopu Investments: Hopu is a large, long-horizon China/Asia investment platform founded by Fang Fenglei, with a similar long-term capital base, large-check consumer and financial services bets, and operational focus paralleling Hillhouse's model.
  • Citic Capital Holdings: Citic Capital is a Hong Kong-headquartered alternatives manager that invests in control and growth equity across China, consumer, healthcare, and industrials — directly comparable to Hillhouse on mandate, ticket size, and Chinese LP / state-affiliated access.
  • HongShan (HSG, formerly Sequoia Capital China): HSG is Hillhouse's most direct and frequent co-investor in Chinese growth and venture rounds, operating a similar multi-stage, multi-vertical China/Asia investment platform with comparable LPs and exit pathways (IPO on HKEX, NASDAQ, STAR).

Emerging players

  • Tencent Investment: Tencent's corporate venture and growth arm is a recurring co-investor and competitor with Hillhouse in Chinese AI, consumer tech, and gaming — co-participating in rounds such as DeepSeek's reported US$50B financing.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights5 records

Customer concentration

Hillhouse Capital financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Hillhouse Capital leadership team

Management profile

Number of profiles

Profiles6 records

Hillhouse Capital subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Hillhouse Capital funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Hillhouse Capital M&A and investment

M&A and investment

M&A

Investments110 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hillhouse Capital

What does Hillhouse Capital do?

Hillhouse Capital operates a research-driven, long-term value investment management platform structured as an evergreen fund (长青基金). The firm invests globally across healthcare, manufacturing, energy transition, enterprise services, and consumer sectors through direct equity, venture, growth, pre-IPO, and post-IPO stages, partnering with high-quality management teams and providing both capital and operational support ("Solution Capital") to portfolio companies. Hillhouse maintains a venture capital subsidiary (GL Ventures/高瓴创投) for early-stage investments and curates industry events (HCare Global Health Industry Summit, Lings Summit) to convene founders and institutional investors.

Is Hillhouse Capital a public or private company?

Hillhouse Capital is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Hillhouse Capital founded?

Hillhouse Capital was founded in 2005.

Where is Hillhouse Capital based?

Hillhouse Capital is headquartered in Zhuhai, China, in the Asia region.

How does Hillhouse Capital make money?

Two revenue lines are on record. Long-term capital investment returns are the primary driver. The others are limited partner management fees and carried interest.

Who are Hillhouse Capital's main competitors?

Broad incumbents on record are Carlyle Group and KKR Asia. Direct peers are IDG Capital, Boyu Capital, Matrix Partners China, CDH Investments (now Bain Capital Asia), Hopu Investments, Citic Capital Holdings and HongShan (HSG, formerly Sequoia Capital China). Tencent Investment is listed as an emerging player.

Does Hillhouse Capital have an API?

No public API is recorded for Hillhouse Capital.

What industry is Hillhouse Capital in?

Hillhouse Capital's product category is Private Equity / Investment Management. Its primary akta.pro industry code is FSANAIAL, Warehouse / Facility Providers to Venture Lenders, with a secondary code of FSANAGAF, Emerging Manager / Seeding Platforms (Multi-Manager). Its NAICS code is 523940 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
ChinaventureWushou Microelectronics completes 100 million yuan Series A financingWushou Microelectronics completed a 100 million yuan Series A financing round. The company will use the funds to expand production capacity of 2.5D and 3D stacked advanced packaging wafer bonding equipment and to develop bonding equipment for small-sized compound semiconductors and optical chips.PedailyWushou Microelectronics completes 100 million yuan Series A financing, increasing investment in advanced packaging and optical chip bonding equipment localization.Wushi Microelectronics completed a 100 million yuan Series A financing on September 29, with participation from Wuyuefeng Innovation, Hillhouse Capital, and others. The funds will expand production capacity for wafer bonding equipment in advanced packaging and strengthen R&D for optical chip bonding, especially for indium phosphide chips.PedailyInvestors are starting to dive in: becoming CFOs, some can take 1% of the market value.Yan Wentao, a former Hillhouse Capital partner, joined DeepSeek as CFO on September 21, becoming the company's first non-technical executive. Investor-turned-CFOs can receive equity incentives up to 1% of market value, with examples including Zhang Yuan at Mixue Ice City and Krishna Rao at Anthropic. The trend reflects companies seeking investor experience for financing and IPO preparation.ChinaventureZhang Yiming has created another 10 billion.Anew Labs, spun off from ByteDance, raised $290 million in its first independent financing, valuing it at $1.5 billion. ByteDance retains a 56% stake, and the round is the largest in China's AI pharmaceutical sector this year. The article notes AI drug discovery still faces clinical efficacy challenges.ChinaventureByte's 'favorite son' unveils the capital landscape of AI pharmaceuticals.Anew Labs, an AI pharmaceutical company spun off from ByteDance, completed a $290 million Series A financing round led by Sequoia China, IDG Capital, and Hillhouse Capital. The post-investment valuation reached $1.5 billion, with China Biopharmaceutical as a strategic investor.Chinaventure高瓴90后合伙人,去DeepSeek当CFO了Yan Wentao, a 90s-born Hillhouse Capital partner, is expected to join DeepSeek as CFO, starting soon. He previously worked at Tencent Investment and H Capital, and DeepSeek is preparing for a Shanghai listing. The move reflects a trend of investors joining portfolio companies as executives.PandailyFullive.ai’s AI Bedside Sleep Device Somni Backs a Bet on ‘Response Learning’Fullive.ai, an AI hardware startup, has completed three funding rounds with Hillhouse Capital and others, and is preparing its first product, Somni, a screen-less bedside sleep device. Somni uses millimeter-wave radar and sensors to track sleep and adjust interventions based on user response, aiming for a 'response model' and mass production this year.DoNewsClipto完成1500万美元融资,估值达2.5亿美元- DoNews快讯Clipto completed a $15 million equity financing on September 2, valuing the AI company at $250 million. The round was led by Sequoia China, Hillhouse Capital, Jiajia Capital, Palm Drive Capital, and individual investors. Funds will support R&D, team expansion, and global market expansion.Chinaventure沃生医药完成 1500 万美元Seed+融资Suzhou Wosheng Pharmaceutical completed a $15 million seed+ financing round on August 31, 2026, led by Matrix Partners with participation from Hillhouse Capital, Eli Lilly Asia Fund, and Boyuan Capital. The company had previously received a $10 million exclusive investment from Qiming Venture Partners.DoNews诺瓦聚变完成 12 亿 Pre-A 系列融资- DoNewsNova Fusion completed 1.2 billion yuan in Pre-A series financing, bringing cumulative funding to 2.4 billion yuan and a valuation over 10 billion yuan. The company aims to achieve its first plasma discharge by end of 2026 and become the first private enterprise to reach a fusion temperature of 100 million °C.